Ascletis Pharma (1672.HK) Q1 2024 Earnings

25MarConfirmed
May 18
Jul 18
Q1 2023
Q1 2024
-0.13
-0.08
-0.04
0.01

Details

Expected EPS
-0.076292618345328
Actual EPS
-0.13022098281847203
Surprise EPS
-0.05
Surprise Percent
+70.69%

Description

Ascletis Pharma (1672.HK) has reported earnings of -0.13022098281847203 per share for Q1 2024.

0 Comments

Share your thoughts